Literature DB >> 6941938

Destruction of erythroleukemia, myelocytic leukemia and Burkitt lymphoma cells by photoactivated protoporphyrin.

Z Malik, M Djaldetti.   

Abstract

The effect of protoporphyrin on erythroid, myeloid and lymphoid leukemic cells and their destruction induced by the photoactivated porphyrin was studied. Friend erythroleukemic cells (FL) and myelocytic leukemic cells (ML) accumulated protoporphyrin in a cap or patch-like pattern observed by fluorescence microscopy. Photoactivated protoporphyrin induced the appearance of "holes" on the cell membrane demonstrated by scanning electron microscopy. On the other hand, Burkitt lymphoma (BL) and mastocytoma (MS) cells accumulated porphyrin intracellularly around the nuclear envelope and as circular profiles, respectively. Photoactivated protoporphyrin induced development of multiple blebs on the cell membrane, and even complete cell destruction. Cytotoxicity of protoporphyrin at short-term incubation periods was determined by [3H]thymidine and [3H]uridine incorporation. Protoporphyrin, unexposed to light, reduced the incorporation of both precursors only to a moderate extent. On the other hand, porphyrin-treated cells exposed to light showed complete inhibition of RNA and DNA synthesis. Long-term exposure of ML and BL cells to porphyrin in the dark induced a nearly 50% inhibition of RNA and DNA synthesis. Although the cytotoxic effect of protoporphyrin in the dark was lower than that of photoactivated porphyrin, this may possess a potential activity in vivo even without illumination.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6941938     DOI: 10.1002/ijc.2910260415

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  The depth of porphyrin in a membrane and the membrane's physical properties affect the photosensitizing efficiency.

Authors:  Adina Lavi; Hana Weitman; Robert T Holmes; Kevin M Smith; Benjamin Ehrenberg
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

2.  Lipid composition affects the rate of photosensitized dissipation of cross-membrane diffusion potential on liposomes.

Authors:  Shany Ytzhak; Joseph P Wuskell; Leslie M Loew; Benjamin Ehrenberg
Journal:  J Phys Chem B       Date:  2010-08-12       Impact factor: 2.991

3.  Photodynamic Therapy with Hexa(sulfo-n-butyl)[60]Fullerene Against Sarcoma In Vitro and In Vivo.

Authors:  Chi Yu; Pinar Avci; Taizoon Canteenwala; Long Y Chiang; Bao J Chen; Michael R Hamblin
Journal:  J Nanosci Nanotechnol       Date:  2016-01

4.  Porphyrin-sensitized photoinactivation of human cells in vitro.

Authors:  J Moan; J V Johannessen; T Christensen; T Espevik; J B McGhie
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

5.  Phototoxicity of protoporphyrin as related to its subcellular localization in mice livers after short-term feeding with griseofulvin.

Authors:  S Sandberg; I Romslo
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

6.  Neonatal exposure to protoporphyrin-activating lighting as a contributing cause of childhood acute lymphocytic leukemia.

Authors:  S A Ben-Sasson; D L Davis
Journal:  Cancer Causes Control       Date:  1992-07       Impact factor: 2.506

7.  Effects of membrane physical parameters on hematoporphyrin-derivative binding to liposomes: a spectroscopic study.

Authors:  E Gross; Z Malik; B Ehrenberg
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

8.  In vivo biological activity of the components of haematoporphyrin derivative.

Authors:  M C Berenbaum; R Bonnett; P A Scourides
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

9.  Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins.

Authors:  Z Malik; H Lugaci
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

10.  Modification of the photodynamic action of delta-aminolaevulinic acid (ALA) on rat pancreatoma cells by mitochondrial benzodiazepine receptor ligands.

Authors:  S L Ratcliffe; E K Matthews
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.